Pharmacokinetic Variability in Anti‐TFPI Therapies: Why Absolute Metrics Matter for Plasma Monitoring
Haemophilia · 2026-07 · 32 (4) · 1093-1095
DOI: 10.1111/hae.70285 ↗Kurz gefasst
Leserbrief in der Zeitschrift Haemophilia, online erschienen am 12.04.2026. Verfasst von Manuel Rodríguez López und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Hemotherapy, Hospital Universitario Álvaro Cunqueiro, Galicia Sur Health Research Institute, Vigo, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Hematology and Hemotherapy, Hospital Universitario Álvaro Cunqueiro, Galicia Sur Health Research Institute, Vigo, Spain.
- Department of Hematology and Hemotherapy, Hospital Universitario La Paz, IdIPaz, Madrid, Spain.
- Department of Hematology and Hemotherapy, Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruña, Spain.
- Department of Hematology and Hemotherapy, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
Zitieren
APA
López, M. R., Roman, M. T. A., Suarez, M. C., Vázquez, R. N., & López, C. A. (2026). Pharmacokinetic Variability in Anti‐TFPI Therapies: Why Absolute Metrics Matter for Plasma Monitoring. Haemophilia, 32(4), 1093-1095. https://doi.org/10.1111/hae.70285
Vancouver
López MR, Roman MTA, Suarez MC, Vázquez RN, López CA. Pharmacokinetic Variability in Anti‐TFPI Therapies: Why Absolute Metrics Matter for Plasma Monitoring. Haemophilia. 2026;32(4):1093-1095. doi:10.1111/hae.70285
BibTeX
@article{Lpez2026,
author = {López, Manuel Rodríguez and Roman, Maria Teresa Alvarez and Suarez, Michael Calviño and Vázquez, Ramiro Núñez and López, Carmen Albo},
title = {Pharmacokinetic Variability in Anti‐TFPI Therapies: Why Absolute Metrics Matter for Plasma Monitoring},
journal = {Haemophilia},
year = {2026},
volume = {32},
number = {4},
pages = {1093--1095},
doi = {10.1111/hae.70285}
}
EUVIMED